HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Vaxart, Inc. (VXRT)
8  -0.85  (-9.6%) 07-02 01:01
Open: 8.45 High: 8.85
Pre.close: 8.85 Low: 7.81
Volume: 28,567,236 Ave vol: 15,055,800
52w High: 14.3 52w Low: 0.25
MA(50): 3.269 MA(200): 1.937
EPS: -0.533 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://vaxart.com
Market Cap (M): 760
Shares Out (M): 95
Vaxart, Inc., a clinical-stage company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes tablet vaccines that are designed to protect against norovirus, seasonal influenza, and respiratory syncytial virus. It is also developing therapeutic immune-oncology vaccines for cervical cancer and dysplasia caused by human papillomavirus. Vaxart, Inc. has a research collaboration agreement with Janssen Vaccines & Prevention B.V. (Janssen) to evaluate the company's proprietary oral vaccine platform for the Janssen universal influenza vaccine program. The company is headquartered in South San Francisco, California.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bullish
KDJ: Bearish RSI: Bearish
Target 1: 11.32 Target 2: 16.70
Resist 1: 9.69 Resist 2: 14.30
Support 1: 2.23 Support 2: 1.86
Company key metrics
Revenue per Share: 0.4572
Net Income per Share: -0.8644
Cash per Share: 0.6264
Book Value per Share: 0.6005
Price to Sales: 1.5966
Price to Book Value: 1.2157
Earnings Yield: -1.1841
Dividend Yield: 0
Debt to Equity: 1.8592
Debt to Assets: 0.6502
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Wed, 01 Jul 2020
Could Investing in Vaxart Make You a Millionaire? - Motley Fool

Wed, 24 Jun 2020
Vaxart, Inc. Set to Join Russell 3000Ā® Index - GlobeNewswire

Thu, 25 Jun 2020
Vaxart, Inc. Signs Memorandum of Understanding with Attwill Medical Solutions Sterilflow, LP - GlobeNewswire

Wed, 01 Jul 2020
Biotech Stock Roundup: GILD Prices Remdesivir, VXRT Rises, ICPT Plunges & More - Yahoo Finance

Tue, 30 Jun 2020
Insider Selling: Vaxart Inc (NASDAQ:VXRT) Director Sells 9,385,386 Shares of Stock - MarketBeat

Tue, 23 Jun 2020
Vaxart, Inc. to Present at the H.C. Wainwright Virtual Fireside Chat Series - GlobeNewswire

HonorStocks, Find Tomorrow's Winners Today

Ā©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.